# Biotricity Inc. (BTCY)

Source: https://www.quantisnow.com/company/BTCY
Generated: 2026-11-17T01:53:57.824Z

- Ticker: BTCY
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- SEC CIK: 0001630113
- Website: biotricity.com

## About

Biotricity, Inc., medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated electrocardiogram (ECG) device and software solution. The company is based in Redwood City, California.

## Latest BTCY news and filings

- 2026-11-12 21:06 UTC [SEC Schedule 13G] [Amendment: SEC Form SCHEDULE 13G/A filed by Biotricity Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-biotricity-inc-6787815)
- 2026-10-07 20:05 UTC [SEC Form RW filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-rw-filed-by-biotricity-inc-6740290)
- 2026-09-25 23:04 UTC [SEC Form 8-K] [Biotricity Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biotricity-inc-filed-sec-form-8-k-leadership-update-financial-statements-6726923)
- 2026-08-19 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-biotricity-inc-6688325)
- 2026-08-17 18:28 UTC [SEC Form NT 10-Q filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-biotricity-inc-6684795)
- 2026-07-14 21:25 UTC [SEC Form 10-K] [SEC Form 10-K filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-biotricity-inc-6637147)
- 2026-06-29 10:07 UTC [SEC Form NT 10-K filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-biotricity-inc-6618088)
- 2026-05-29 20:05 UTC [SEC Form PRE 14C filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-pre-14c-filed-by-biotricity-inc-6579055)
- 2026-05-01 21:28 UTC [SEC Form 8-K] [Biotricity Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biotricity-inc-filed-sec-form-8-k-entry-into-a-material-6527499)
- 2026-02-18 22:30 UTC [SEC Form 8-K] [Biotricity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biotricity-inc-filed-sec-form-8-k-results-of-operations-and-6400416)
- 2026-02-11 21:29 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-biotricity-inc-6386913)
- 2026-02-11 21:00 UTC [Earnings] [Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA](https://www.quantisnow.com/insight/biotricity-delivers-strong-q3-fiscal-2026-performance-growing-revenue-momentum-6386425)
- 2026-02-05 21:15 UTC [Dividends] [Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th](https://www.quantisnow.com/insight/biotricity-to-announce-continued-growth-in-fiscal-2026-third-quarter-6377918)
- 2025-12-22 22:29 UTC [SEC Form S-1] [SEC Form S-1 filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-biotricity-inc-6325851)
- 2025-11-18 21:05 UTC [SEC Form 8-K] [Biotricity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biotricity-inc-filed-sec-form-8-k-results-of-operations-and-6284847)
- 2025-11-14 21:00 UTC [Earnings] [Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026](https://www.quantisnow.com/insight/biotricity-strengthens-path-to-scalable-profitability-with-sustained-margins-operational-6280157)
- 2025-11-14 20:38 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-biotricity-inc-6280124)
- 2025-11-07 13:30 UTC [Dividends] [Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14th](https://www.quantisnow.com/insight/biotricity-to-host-fiscal-2026-second-quarter-financial-results-and-6267439)
- 2025-09-09 13:32 UTC [Health-E Commerce® and Biotricity® Collaborate to Expand Remote Cardiac Monitoring with Bioheart® for Flexible Spending Account (FSA) and Health Savings Account (HSA) Users](https://www.quantisnow.com/insight/health-e-commerce-and-biotricity-collaborate-to-expand-remote-cardiac-monitoring-6194616)
- 2025-09-03 12:15 UTC [Biotricity and B-Secur Target the Consumer Wearables Market with Expansion of Next-Gen Cardiac Monitoring Platform](https://www.quantisnow.com/insight/biotricity-and-b-secur-target-the-consumer-wearables-market-with-expansion-6187125)
- 2025-08-14 12:15 UTC [Earnings] [Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins](https://www.quantisnow.com/insight/biotricity-reinforces-growth-trajectory-kicking-off-fiscal-2026-with-strong-6164638)
- 2025-08-14 11:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-biotricity-inc-6164362)
- 2025-08-12 12:15 UTC [Dividends] [Biotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14th](https://www.quantisnow.com/insight/biotricity-to-host-fiscal-2026-first-quarter-financial-results-and-6159771)
- 2025-07-17 13:33 UTC [Earnings] [Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach](https://www.quantisnow.com/insight/biotricity-delivers-strong-fiscal-year-2025-results-with-revenue-growth-6123386)
- 2025-07-15 21:27 UTC [SEC Form 10-K] [SEC Form 10-K filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-biotricity-inc-6121064)
- 2025-07-15 21:05 UTC [Dividends] [Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th](https://www.quantisnow.com/insight/biotricity-to-host-fiscal-2025-fourth-quarter-financial-results-and-6121003)
- 2025-07-01 01:20 UTC [SEC Form NT 10-K filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-biotricity-inc-6104602)
- 2025-04-08 12:15 UTC [Dividends] [Biotricity Recognized by Financial Times as One of 2025's Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period Analyzed](https://www.quantisnow.com/insight/biotricity-recognized-by-financial-times-as-one-of-2025s-fastest-growing-5980689)
- 2025-03-12 12:15 UTC [Dividends] [Biotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease Management](https://www.quantisnow.com/insight/biotricity-expands-ip-portfolio-strategy-with-14-new-patents-reinforcing-5940017)
- 2025-02-20 17:08 UTC [SEC Form 10-Q] [Amendment: SEC Form 10-Q/A filed by Biotricity Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-qa-filed-by-biotricity-inc-5899600)
- 2025-02-20 13:15 UTC [Earnings] [Biotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025](https://www.quantisnow.com/insight/biotricity-delivers-record-margins-record-revenues-and-record-cashflows-with-5899264)
- 2025-02-19 22:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-biotricity-inc-5897850)
- 2025-02-17 13:15 UTC [Earnings Date] [Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11%](https://www.quantisnow.com/insight/biotricity-announces-cashflow-breakeven-with-biggest-quarter-in-history-and-5892427)
- 2025-02-14 22:11 UTC [SEC Form NT 10-Q filed by Biotricity Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-biotricity-inc-5891682)
- 2025-01-15 15:01 UTC [Dividends] [Biotricity and B-Secur Partner to Launch the Most Comprehensive Device-Neutral Ambulatory Cardiac Monitoring Platform](https://www.quantisnow.com/insight/biotricity-and-b-secur-partner-to-launch-the-most-comprehensive-device-neutral-5846689)
- 2024-12-27 13:15 UTC [Dividends] [Biotricity Produces Largest Inventory in its History to Meet Accelerated Demand](https://www.quantisnow.com/insight/biotricity-produces-largest-inventory-in-its-history-to-meet-accelerated-5825681)
- 2024-12-03 13:15 UTC [Dividends] [Biotricity Achieves Positive Free Cash Flow Milestone](https://www.quantisnow.com/insight/biotricity-achieves-positive-free-cash-flow-milestone-5797234)
- 2024-11-20 02:41 UTC [SEC Form 8-K] [Biotricity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biotricity-inc-filed-sec-form-8-k-results-of-operations-and-5784072)
- 2024-11-15 13:15 UTC [Earnings] [Biotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025](https://www.quantisnow.com/insight/biotricity-achieves-improved-margins-and-efficiencies-and-year-over-year-sales-growth-5778189)
- 2024-11-14 23:06 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Biotricity Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-biotricity-inc-5777453)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BTCY
- Earnings history: https://www.quantisnow.com/earnings/BTCY
- Dividend history: https://www.quantisnow.com/dividends/BTCY
- Insider transactions: https://www.quantisnow.com/insiders/BTCY
- Options chain: https://www.quantisnow.com/options/BTCY
- SEC 8-K filings only: https://www.quantisnow.com/company/BTCY/8-k
- RSS and alerts for BTCY: https://www.quantisnow.com/docs/rss-feeds.md
